Biotech At Risk: Industry Coalition Report Calls For Broad Federal Reforms
This article was originally published in The Gray Sheet
Northern California life sciences industry coalition BayBio is calling for federal and state policy changes to help grow the field, including more National Institutes of Health funding, CMS reforms and a $175-million increase in FDA appropriations for fiscal 2009
You may also be interested in...
Group purchasing organization and patent reforms top the Medical Device Manufacturers Association's priorities for 2008
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.